FdaApplication

NDA 214759

Back to search

Identifiers

Properties

PropertyValue
applicant_nameMEDEXUS PHARMA INC
application_typeNDA
approval_date2025-01-21

Products (2)

ProductActive ingredientStrengthDosage form
GRAFAPEXTREOSULFAN1GM/VIALPOWDER;INTRAVENOUS
GRAFAPEXTREOSULFAN5GM/VIALPOWDER;INTRAVENOUS

2 products